Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Amisulpride FCT 400 mg vs Solian 400 mg in healthy Thai volunteers (fasting)
TCTR20190712004Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of amisulpride (2 arms), sponsored by Bio-innova. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
amisulpride
Beyond the preview
Go deeper on TCTR20190712004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190712004.